Health Law & Business News

Hospital Group Fights Potential Limits on Drug Discount Program

Sept. 18, 2018, 5:42 PM

The American Hospital Association is trying to dodge potentially restrictive regulation of a federal drug discount program by pushing hospitals to voluntarily report their savings.

The program, called 340B, requires drug companies to give discounts to hospitals with predominantly low-income patients. It has garnered criticism from some lawmakers who say it has become unwieldy and lacks transparency. The brand drug industry has also said the program in some cases benefits hospitals more than patients and is causing drug prices to rise.

Consequently, the AHA is encouraging 340B hospitals across the country to publicly disclose their estimated savings through the...

To read the full article log in. To learn more about a subscription click here.